Breaking Through the Investment Gap: Mark Andrews Discusses British Patient Capital's Life Sciences Fund
In this interview, we speak with Mark Andrews, Investment Director, Life Sciences, Funds at British Patient Capital, the largest domestic investor into UK venture capital opportunities, including pharmaceutical industry and biotech. Mark sheds light on the investment strategy of British Patient Capital, the specific biotech and healthcare sectors that they prioritise, the eligibility criteria for prospective startups or projects, and the major shifts that can be anticipated in the UK's life science industry in the coming years.
Topics: Startups & Deals